The newly licensed Lumir Lab based on the Hebrew University campus will be the base for the research by Gynica.
Gynica will collaborate with Lumir Lab and look at treatment for endometriosis. The condition is where tissue from the uterine lining migrates to other organs and affects approximately 180 million women worldwide.
The female reproductive system contains the most endocannabinoid receptors after the brain according to Gynica, and studies show that medical cannabis has positive effects on the symptoms of endometriosis.
More research is required to determine the cannabinoids that eliminate lesions, reduce pain and also ensuring that it does not have a negative impact on the ovulation cycle.
The hope is that with more research and scientific base it will give the medical community the legitimacy of cannabis based treatments.
Source – Israel 21c
Image – Mwooten/pixabay